Latest Healthcare in India Stories
NEW DELHI, October 25, 2010 /PRNewswire/ -- - Experts Say Universal Access to Preventive and Curative Intervention is Crucial Health experts participating at a roundtable organised by India Health Progress(IHP) on economic and social impact of non-communicable diseases in India are of the opinion that a concerted effort is required to address the growing burden. A review of variety of papers assessing the burden of non-communicable diseases in India has just been released by...
REDWOOD CITY, Calif., Oct. 4 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. announced today that James H. Welch has joined the company as Chief Financial Officer.
CALGARY, Oct. 4 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and Chief Executive Officer of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the 9th Annual BIO Investor Forum on Wednesday, October 6th, 2010 at 8:00 a.m. PDT.
CALGARY, Sept. 27 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and Chief Executive Officer of Oncolytics Biotech Inc.
SINGAPORE, Sept. 23 /PRNewswire/ -- S*BIO Pte Ltd today announced a US$5 million investment by Mitsui Ventures that will support the continued development of S*BIO's clinical programs.
SAN DIEGO, Sept.
CALGARY, Sept. 9 /PRNewswire-FirstCall/ - Mr. Doug Ball, Chief Financial Officer of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 14th, 2010 at 10:25 a.m. EDT.
SAN DIEGO, Sept. 7 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc.
SAN DIEGO, Sept. 1 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the Rodman & Renshaw Annual Global Investment Conference on Tuesday September 14, 2010 at 11:40 a.m.
OXFORD, England and LANGHORNE, Pennsylvania, September 1, 2010 /PRNewswire/ -- EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced the appointment of Stephen A.
- A transitional zone between two communities containing the characteristic species of each.